(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe...
Stats | |
---|---|
Dagens volum | 201 691 |
Gjennomsnittsvolum | 335 849 |
Markedsverdi | 11.42B |
EPS | $0 ( 2024-02-14 ) |
Last Dividend | $0.170 ( 2023-09-06 ) |
Next Dividend | $0 ( N/A ) |
P/E | 163.25 |
ATR14 | $0.0930 (0.08%) |
Volum Korrelasjon
Pro Medicus Ltd Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Pro Medicus Ltd Korrelasjon - Valuta/Råvare
Pro Medicus Ltd Økonomi
Annual | 2023 |
Omsetning: | $124.90M |
Bruttogevinst: | $92.37M (73.95 %) |
EPS: | $0.580 |
FY | 2023 |
Omsetning: | $124.90M |
Bruttogevinst: | $92.37M (73.95 %) |
EPS: | $0.580 |
FY | 2022 |
Omsetning: | $93.46M |
Bruttogevinst: | $70.28M (75.20 %) |
EPS: | $0.430 |
FY | 2021 |
Omsetning: | $67.84M |
Bruttogevinst: | $67.35M (99.28 %) |
EPS: | $0.297 |
Financial Reports:
No articles found.
Pro Medicus Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.120 (N/A) |
$0 (N/A) |
$0.130 (N/A) |
$0 (N/A) |
$0.170 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0100 | 2001-03-16 |
Last Dividend | $0.170 | 2023-09-06 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 45 | -- |
Total Paid Out | $1.503 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.27 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.13 | |
Div. Directional Score | 9.40 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
MOT.AX | Ex Dividend Knight | 2023-08-31 | Monthly | 0 | 0.00% | |
VEA.AX | Ex Dividend Junior | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
DTL.AX | Ex Dividend Knight | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
OPH.AX | No Dividend Player | 2023-06-30 | Annually | 0 | 0.00% | |
AGL.AX | Ex Dividend Knight | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
GEM.AX | Ex Dividend Junior | 2023-09-07 | Annually | 0 | 0.00% | |
QRI.AX | Ex Dividend Junior | 2023-09-05 | Monthly | 0 | 0.00% | |
BFG.AX | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
JLG.AX | Ex Dividend Junior | 2023-09-01 | Annually | 0 | 0.00% | |
SKC.AX | Ex Dividend Junior | 2023-09-07 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.490 | 1.500 | 0.190 | 0.285 | [0 - 0.5] |
returnOnAssetsTTM | 0.326 | 1.200 | 10.00 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.468 | 1.500 | 5.91 | 8.87 | [0.1 - 1] |
payoutRatioTTM | 0.449 | -1.000 | 5.51 | -5.51 | [0 - 1] |
currentRatioTTM | 7.49 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.45 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.25 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00721 | -1.500 | 9.88 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.658 | 2.00 | 9.67 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00970 | -1.500 | 9.96 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.741 | 1.000 | 0.982 | 0.982 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.673 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 48.73 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.664 | 0.800 | 8.91 | 7.13 | [0.5 - 2] |
Total Score | 11.67 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 163.86 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.468 | 2.50 | 7.37 | 8.87 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.658 | 2.00 | 9.78 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.320 | 1.500 | 2.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.449 | 1.500 | 5.51 | -5.51 | [0 - 1] |
pegRatioTTM | 3.78 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.530 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 7.13 |
Pro Medicus Ltd
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.